Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 30, 2017

DrugPatentWatch Database Preview

Diphenhydramine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for diphenhydramine hydrochloride and what is the scope of diphenhydramine hydrochloride patent protection?

Diphenhydramine hydrochloride
is the generic ingredient in sixteen branded drugs marketed by Whiteworth Town Plsn, Elkins Sinn, Pioneer Pharms, Cenci, Alpharma Us Pharms, Mutual Pharm, Impax Labs, Cumberland Swan, Pharm Assoc, Halsey, Parke Davis, Hi Tech Pharma, West-ward Pharms Int, Morton Grove, Alra, Kv Pharm, Bel Mar, Heather, Warner Chilcott, Fresenius Kabi Usa, Pvt Form, Watson Labs, Vangard, Sandoz, Nexgen Pharma Inc, Roxane, Lederle, Purepac Pharm, Barr, Lannett, Superpharm, Usl Pharma, Hospira, Newtron Pharms, Mcneil Cons, Silarx, Perrigo, Ivax Sub Teva Pharms, App Pharms, Lyphomed, Hikma Intl Pharms, Watson Labs Inc, Teva, Bundy, Anabolic, LNK, Wyeth Ayerst, Naska, Eurohlth Intl Sarl, Abraxis Pharm, Mk Labs, Sun Pharm Inds, Valeant Pharm Intl, Intl Medication, Mylan Institutional, Strides Pharma, Pfizer, Bionpharma Inc, and Bayer Hlthcare, and is included in ninety-two NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-three drug master file entries for diphenhydramine hydrochloride. Seventeen suppliers are listed for this compound.

Summary for Generic Name: diphenhydramine hydrochloride

Drug Master File Entries: see list23
Suppliers / Packagers: see list17
Bulk Api Vendors: see list64
Clinical Trials: see list1,072
Patent Applications: see list9,944
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:diphenhydramine hydrochloride at DailyMed

Pharmacology for Ingredient: diphenhydramine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
diphenhydramine hydrochloride
CAPSULE;ORAL080845-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Intl Medication
diphenhydramine hydrochloride
INJECTABLE;INJECTION084094-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Purepac Pharm
diphenhydramine hydrochloride
CAPSULE;ORAL085150-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Hikma Intl Pharms
diphenhydramine hydrochloride
CAPSULE;ORAL083567-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
diphenhydramine hydrochloride
ELIXIR;ORAL088680-001May 31, 1985DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Uncover prior art in abandoned patent applications and expired patents
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus